Consumo de Losartán multifuente en un establecimiento farmacéutico de Trujillo, octubre 2018 – marzo 2019
No Thumbnail Available
Date
2021
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente informe tuvo como objetivo determinar el consumo de losartán multifuente expendido en un establecimiento farmacéutico de Trujillo en el periodo de Octubre 2018 – Marzo 2019 con el fin de contribuir al uso racional y eficiente de esta droga. Es un estudio descriptivo, transversal y retrospectivo. Los datos de losartán multifuente (50 mg y 100 mg) fueron obtenidos de los registros diarios informatizados de las ventas de medicamentos contenidos en la base de datos del sistema de ventas. Luego fueron procesados en una hoja de cálculo del programa Microsoft Excel 2017, se utilizó como parámetro de medida la Dosis Diaria Definida (DDD/ 1000 hb. / Día). Se obtuvieron los siguientes resultados; el consumo mensual de losartán multifuente expresado en unidades tuvo su mayor consumo en el mes de diciembre siendo losartán 50 mg 1085 unidades, el consumo semestral fue 4661 unidades; así mismo 0.0185 DDD/1000 hb /día; el consumo semestral de losartán multifuente fue 0.0795 DDD/1000 hb /día expresado en medida la Dosis Diaria Definida; el costo semestral de losartán multifuente fue S/.972.70 nuevos soles del total de 4661 unidades.
ABSTRACT The objective of this report was to determine the consumption of multi-source losartan in a pharmaceutical establishment in Trujillo in the period October 2018 - March 2019 in order to contribute to the rational and efficient use of this drug. It is a descriptive, cross-sectional and retrospective study. The multi-source losartan data (50 mg and 100 mg) were obtained from the computerized daily records of drug sales contained in the sales system database. Then they were processed in a spreadsheet of the Microsoft Excel 2017 program, the Defined Daily Dose (DDD / 1000 hb. / Day) was used as a measurement parameter. The following results were obtained; the monthly multi-source losartan expressed in units had its highest consumption in the month of December being losartan 50 mg 1085 units, the semester consumption was 4661 units; likewise 0.0185 DDD / 1000 hb / day; the semiannual consumption of multi - source losartan was 0.0795 DDD / 1000 hb / day expressed as the Defined Daily Dose; the semiannual cost of multi-source losartan was S / .972.70 nuevos soles out of a total of 4661 units.
ABSTRACT The objective of this report was to determine the consumption of multi-source losartan in a pharmaceutical establishment in Trujillo in the period October 2018 - March 2019 in order to contribute to the rational and efficient use of this drug. It is a descriptive, cross-sectional and retrospective study. The multi-source losartan data (50 mg and 100 mg) were obtained from the computerized daily records of drug sales contained in the sales system database. Then they were processed in a spreadsheet of the Microsoft Excel 2017 program, the Defined Daily Dose (DDD / 1000 hb. / Day) was used as a measurement parameter. The following results were obtained; the monthly multi-source losartan expressed in units had its highest consumption in the month of December being losartan 50 mg 1085 units, the semester consumption was 4661 units; likewise 0.0185 DDD / 1000 hb / day; the semiannual consumption of multi - source losartan was 0.0795 DDD / 1000 hb / day expressed as the Defined Daily Dose; the semiannual cost of multi-source losartan was S / .972.70 nuevos soles out of a total of 4661 units.
Description
Keywords
Losartán, consumo, DDD